176 related articles for article (PubMed ID: 14500726)
1. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
2. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor.
Dupré DJ; Thompson C; Chen Z; Rollin S; Larrivée JF; Le Gouill C; Rola-Pleszczynski M; Stanková J
Cell Signal; 2007 Oct; 19(10):2068-79. PubMed ID: 17609120
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif.
Chen Z; Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2002 Mar; 277(9):7356-62. PubMed ID: 11729201
[TBL] [Abstract][Full Text] [Related]
4. Role of mammalian vacuolar protein-sorting proteins in endocytic trafficking of a non-ubiquitinated G protein-coupled receptor to lysosomes.
Hislop JN; Marley A; Von Zastrow M
J Biol Chem; 2004 May; 279(21):22522-31. PubMed ID: 15024011
[TBL] [Abstract][Full Text] [Related]
5. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor.
Lukashova V; Asselin C; Krolewski JJ; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2001 Jun; 276(26):24113-21. PubMed ID: 11309383
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
7. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.
Liang W; Fishman PH
J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
9. Rescue of internalization-defective platelet-activating factor receptor function by EBP50/NHERF1.
Dupré DJ; Rola-Pleszczynski M; Stankova J
J Cell Commun Signal; 2012 Dec; 6(4):205-16. PubMed ID: 22878922
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 attenuates PAF-induced MMP-2 production via down-regulation of PAF receptor expression in vascular smooth muscle cells.
Kim YH; Bae JU; Lee SJ; Park SY; Kim CD
Vascul Pharmacol; 2015 Sep; 72():35-42. PubMed ID: 25967595
[TBL] [Abstract][Full Text] [Related]
11. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes.
Zhuang Q; Bastien Y; Mazer BD
J Immunol; 2000 Sep; 165(5):2423-31. PubMed ID: 10946267
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
Alwan HA; van Zoelen EJ; van Leeuwen JE
J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production.
Ahamed J; Ali H
J Biol Chem; 2002 Jun; 277(25):22685-91. PubMed ID: 11934880
[TBL] [Abstract][Full Text] [Related]
14. Cross-desensitization among receptors for platelet activating factor and peptide chemoattractants. Evidence for independent regulatory pathways.
Richardson RM; Haribabu B; Ali H; Snyderman R
J Biol Chem; 1996 Nov; 271(45):28717-24. PubMed ID: 8910508
[TBL] [Abstract][Full Text] [Related]
15. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals.
Brown SL; Jala VR; Raghuwanshi SK; Nasser MW; Haribabu B; Richardson RM
J Immunol; 2006 Sep; 177(5):3242-9. PubMed ID: 16920964
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
van Kerkhof P; Alves dos Santos CM; Sachse M; Klumperman J; Bu G; Strous GJ
Mol Biol Cell; 2001 Aug; 12(8):2556-66. PubMed ID: 11514635
[TBL] [Abstract][Full Text] [Related]
17. Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation.
Chen Z; Rola-Pleszczynski M; Stankova J
Cell Signal; 2003 Sep; 15(9):843-50. PubMed ID: 12834809
[TBL] [Abstract][Full Text] [Related]
18. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor.
Su X; Kong C; Stahl PD
J Biol Chem; 2007 Jul; 282(29):21278-84. PubMed ID: 17545148
[TBL] [Abstract][Full Text] [Related]
19. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
[TBL] [Abstract][Full Text] [Related]
20. A role for the small GTPase Rab21 in the early endocytic pathway.
Simpson JC; Griffiths G; Wessling-Resnick M; Fransen JA; Bennett H; Jones AT
J Cell Sci; 2004 Dec; 117(Pt 26):6297-311. PubMed ID: 15561770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
